The Wall Street Journal is reporting that
Caremark Rx shareholders voted to approve a $26.5 billion takeover offer from drugstore operator CVS. The approval capped a monthslong bidding war between CVS and Express Scripts for the pharmacy-benefits manager. Express Scripts’ offer was higher than CVS’s, at about $27.2 billion, but would’ve taken longer to clear regulatory hurdles.